Current projects

The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) funds cancer research, policy projects and events that foster public discussion around health care and health policy to benefit the public good. The Foundation serves as an honest, independent broker of ideas and actions designed to improve the quality of care patients experience.  

In 2019, JKTG Foundation work focuses on rethinking health care quality, emerging cancer research and uses for real-world evidence. Below are initiatives we support.  For a robust listing of work to date, read a summary.

Research & Policy Analysis | 

  • Continuing to fund emerging cancer research with the Johns Hopkins University School of Medicine and Robert Ivkov, Ph.D., to explore nanoparticles, their interface with the immune system, and potentially the interaction of the immune system with the  tumor environment in the treatment of cancer.

 

  • Supporting The Jayne Koskinas Ted Giovanis Breast Cancer Research Consortium at The Wistar Institute to fund highly synergistic, multidisciplinary research projects dedicated to advancing breast cancer research.

 

  • Further investigation of uses for real-world evidence that improve patient care in the drug approval and post-approval process through continued work with the Bipartisan Policy Center as well as support of the Observational Health Data Sciences and Informatics program (OHDSI).

 

  • Investigating new policy proposals and changes to Medicare and wider health care coverage with patients in mind, advocating against harmful rules, legislation and policy that impact the quality of care patients experience.

 

  • Ongoing analysis of health care quality to identify whether America’s health system can more fairly and effectively accelerate improvements in patient care.

 

Events |

 

  • Hosting the annual Jayne Koskinas Memorial Symposium featuring leading cancer researchers and fostering collaboration within the health research discipline.

 

  • Building collaborations among cancer researchers by funding basic and applied research in coordination with the National Institutes of Health (NIH), offering awards to NIH-sponsored ideas and Innovation Lab fellows as well as work with other partners.

 

  • Continued sponsorship of the annual Wall Street Comes to Washington Health Policy Roundtable where financial experts discuss trends shaping and influencing the current health care market.